Editorial
 INDECISION ON ANALGIN   
 Wednesday, May 15, 2013 
 Once again a demand for banning analgin, one of the oldest analgesics marketed and widely used in the country, has come to the fore. 
  Past Editorial...  
TODAY'S NEWS
16:00  [IST]Sanofi's pivotal phase III JAKARTA study for JAK2 inhibitor in myelofibrosis meets primary endpoint
15:00  [IST]AbbVie, Galapagos extend GLPG0634 clinical development pact to include Crohn's disease
14:00  [IST]St. Jude Medical's ILUMIEN OPTIS PCI Optimization System receives CE Mark approval
13:00  [IST]A*STAR, Cytos Biotech begin phase I trial with H1N1 influenza vaccine candidate
12:00  [IST]MultiCell seeks US patent for targeted delivery of noncoding Micro RNAs to treat liver cancer
11:00  [IST]Mylan launches generic Tricor tablets
more news >>
TOP NEWS
08:00  [IST]KPMA wants state govt to declare pharma manufacturing a thrust sector
08:00  [IST]Brain League expects developing nations to follow India, may frame tough patent laws
08:00  [IST]Grand Challenge Canada grants 1 lakh CAD to Sathguru Management Consultants for vaccine delivery solution
08:00  [IST]Directorate of pharmacy need to be established in each state to check drug related matters
08:00  [IST]Reckitt Benckiser & Save the Children allocate $35.5 mn to prevent fatality among children
08:00  [IST]Health Research Dept plans 10 model rural units to take health technology to end users
more news >>
YESTERDAY'S NEWS
18:00  [IST]Boston Scientific enrols first patient in clinical investigation evaluating the use of WallFlex Biliary RX Stent
17:00  [IST]GENFIT's GFT505 reduces risk of cardiovascular events through its action on remnant cholesterol
16:00  [IST]Almac secures BBSRC programme with UCL focussed on metagenomics and enzyme discovery
15:20  [IST]GE Healthcare inks PPP pact with Maharashtra to equip 22 hospitals with latest diagnostic facilities
15:00  [IST]Illumina enters partnerships with leading providers for automate TruSeq and Nextera sample preparation kits
14:00  [IST]Cardica completes enrollment in European study for surgical cutting & stapling device, MicroCutter XCHANGE 30
more news >>
INTERVIEW  
Industry dynamics such as patent cliff will impact companies differently: Rajiv Malik
rajiv_malik.jpgRajiv Malik, president, Mylan Inc.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the industry support the health ministry's directive to state licensing authorities to grant manufacturing licences in generic names only?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |